JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 462.25 Million CNY | 5.76% |
| 2022 | 437.06 Million CNY | 34.17% |
| 2021 | 325.74 Million CNY | -6.86% |
| 2020 | 349.75 Million CNY | -78.29% |
| 2019 | 1.61 Billion CNY | 146.32% |
| 2018 | 654.02 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 497.87 Million CNY | 7.71% |
| 2024 Q2 | 497.87 Million CNY | 0.0% |
| 2023 FY | 462.25 Million CNY | 5.76% |
| 2023 Q3 | 462.25 Million CNY | -9.71% |
| 2023 Q2 | 511.95 Million CNY | 0.0% |
| 2023 Q1 | 511.95 Million CNY | 17.14% |
| 2023 Q4 | 462.25 Million CNY | 0.0% |
| 2022 Q4 | 437.06 Million CNY | 0.0% |
| 2022 Q2 | 293.02 Million CNY | 0.0% |
| 2022 Q1 | 293.02 Million CNY | -10.05% |
| 2022 FY | 437.06 Million CNY | 34.17% |
| 2022 Q3 | 437.06 Million CNY | 49.16% |
| 2021 Q1 | 306.84 Million CNY | -12.27% |
| 2021 FY | 325.74 Million CNY | -6.86% |
| 2021 Q4 | 325.74 Million CNY | 0.0% |
| 2021 Q3 | 325.74 Million CNY | 6.16% |
| 2021 Q2 | 306.84 Million CNY | 0.0% |
| 2020 FY | 349.75 Million CNY | -78.29% |
| 2020 Q1 | 2.94 Billion CNY | 83.1% |
| 2020 Q3 | 349.75 Million CNY | -88.14% |
| 2020 Q2 | 2.94 Billion CNY | 0.0% |
| 2020 Q4 | 349.75 Million CNY | 0.0% |
| 2019 Q3 | 1.61 Billion CNY | 0.0% |
| 2019 FY | 1.61 Billion CNY | 146.32% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | 1.61 Billion CNY | 0.0% |
| 2018 FY | 654.02 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 50.26 Million USD | -819.662% |
| Skye Bioscience, Inc. | 14.07 Million USD | -3184.902% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -683.303% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -57054.108% |
| Qrons Inc. | 1.48 Million USD | -30950.914% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 15.9 Million USD | -2806.436% |
| CSL Limited | 18.62 Billion USD | 97.518% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -537.854% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -4783.402% |
| Regen BioPharma, Inc. | 5.45 Million USD | -8369.98% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -517.003% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -1034129.014% |
| Rebus Holdings, Inc. | 5.24 Million USD | -8718.371% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -1684947.206% |
| Neon Bloom, Inc. | 1.22 Million USD | -37598.1% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -229746.954% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -767.196% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -4724.232% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -109552.298% |
| SQZ Biotechnologies Company | 50.03 Million USD | -823.797% |
| Intellipharmaceutics International Inc. | 12 Million USD | -3749.346% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -11902.288% |
| Mesoblast Limited | 188.44 Million USD | -145.302% |
| Marizyme, Inc. | 26.67 Million USD | -1632.884% |
| Genus plc | 485 Million USD | 4.689% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -7811.843% |
| Pharming Group N.V. | 244.07 Million USD | -89.394% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -22896.473% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -18270.379% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -12064.711% |
| ContraFect Corporation | 32.53 Million USD | -1320.98% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -23231.002% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -11976.842% |
| IMV Inc. | 37.93 Million USD | -1118.626% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -3824.702% |
| MultiCell Technologies, Inc. | 1617.67 USD | -28575505.655% |
| ONE Bio Corp. | 27.49 Million USD | -1581.198% |
| Accustem Sciences Inc. | 1.07 Million USD | -42731.94% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -497.103% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -21755.504% |
| Q BioMed Inc. | 8.13 Million USD | -5583.788% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -457.375% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -8882.819% |
| Biomind Labs Inc. | 1.49 Million USD | -30745.809% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | -289.362% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -5012.244% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -2411.811% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -32138.76% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -325216.865% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -7945.134% |
| GB Sciences, Inc. | 5.41 Million USD | -8432.61% |
| Alpha Cognition Inc. | 7.16 Million USD | -6351.829% |
| HST Global, Inc. | 593.59 Thousand USD | -77774.739% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -36610.735% |
| Halberd Corporation | 728.71 Thousand USD | -63334.465% |
| Enzolytics Inc. | 365.26 Million USD | -26.553% |
| Agentix Corp. | 2.51 Million USD | -18312.622% |
| Resverlogix Corp. | 67.39 Million USD | -585.885% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -55014.029% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | -3.89% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -26869.603% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -1768.013% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -3783.517% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -12512.232% |
| AVAX Technologies, Inc. | 3.99 Million USD | -11474.575% |
| Zenith Capital Corp. | 27.56 Thousand USD | -1676634.738% |
| Genscript Biotech Corporation | 1.32 Billion USD | 65.135% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -193594.218% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -12278.712% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -67795.992% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -16947.205% |
| Kadimastem Ltd | 3.5 Million USD | -13089.06% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -690570.711% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -99374.929% |
| LadRx Corporation | 2.2 Million USD | -20906.731% |
| Cell Source, Inc. | 15.8 Million USD | -2824.447% |
| Regen BioPharma, Inc. | 5.45 Million USD | -8369.98% |
| NovAccess Global Inc. | 7.86 Million USD | -5780.61% |
| Affymax, Inc. | 8.87 Million USD | -5110.901% |
| Itoco Inc. | 1.65 Million USD | -27862.297% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -22432.018% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -7541.908% |
| Mobile Lads Corp. | 1.31 Million USD | -35093.0% |
| CytoDyn Inc. | 127.89 Million USD | -261.439% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -1105809.232% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -29411.35% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -4085.124% |
| SYBLEU INC | 681.41 Thousand USD | -67738.301% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -7475.651% |
| International Stem Cell Corporation | 5.27 Million USD | -8659.883% |
| Bioxytran, Inc. | 3.24 Million USD | -14125.542% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -73765.828% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -9911.836% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -1027.571% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -1976.169% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -22723.243% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -8338.463% |
| Neutra Corp. | 973.52 Thousand USD | -47382.818% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1493.172% |
| PureTech Health plc | 125.58 Million USD | -268.09% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -12203.53% |
| IXICO plc | 1.9 Million USD | -24225.683% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -2151.737% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -347.388% |
| CSL Limited | 18.62 Billion USD | 97.518% |
| Cellectis S.A. | 249.36 Million USD | -85.371% |